Comparative effects of topical anthralin and difluoromethylornithine (alpha DFMO) on epidermal polyamine concentration in psoriasis.
D000873:Anthracenes / Q000627:therapeutic use*; D000875:Anthralin / Q000627:therapeutic use*; D000518:Eflornithine; D006801:Humans; D009952:Ornithine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011073:Polyamines / Q000378:metabolism*; D011565:Psoriasis / Q000188:drug therapy / Q000378:metabolism*; D012867:Skin / Q000378:metabolism*
D000873:Anthracenes; D011073:Polyamines; D009952:Ornithine; D000875:Anthralin; D000518:Eflornithine